Skip to content

LivaNova LIVN Free cash flow yield

Free cash flow yield at other companies

Abbott logo
AbbottABT
4.1%+1.2pp
Haemonetics logo
HaemoneticsHAE
9.9%+5.5pp
Medtronic logo
MedtronicMDT
5.2%+0.4pp
ResMed logo
ResMedRMD
5.4%+0.6pp
Boston Scientific logo
Boston ScientificBSX
3.7%+1.7pp
Stryker logo
StrykerSYK
3.6%+1.1pp

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Based on trailing twelve months.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's free cash flow yield?
LivaNova (LIVN) reported free cash flow yield of 4.6% in Q1 2026.
How has LivaNova's free cash flow yield changed year-over-year?
LivaNova's free cash flow yield decreased by 32.0% year-over-year, from 6.8% to 4.6%.
What is the long-term trend for LivaNova's free cash flow yield?
Over 3 years (2021 to 2025), LivaNova's free cash flow yield has grown at a 46.1% compound annual growth rate (CAGR), from 1.7% to 5.2%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.